Volume 25, Issue 8 (Oct-Nov 2018)
RJMS 2018, 25(8): 24-32 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
mohebbi S, daneshi A, Ebrahimnejad S, Kalantari F. Evaluation of locally administered autologous platelet rich plasma in reducing symptoms of recurrent sinonasal polyposis following endoscopic sinus surgery. RJMS 2018; 25 (8) :24-32
URL: http://rjms.iums.ac.ir/article-1-5103-en.html
URL: http://rjms.iums.ac.ir/article-1-5103-en.html
Iran University of Medical Sciences , Kalantari.f@iums.ac.ir
Abstract: (3175 Views)
Background: For many patients with sinonasal polyposis, functional endoscopic sinus surgery (FESS) has provided much needed relief from a condition that, by its daily aggravation, can significantly reduce quality of life. In some patients, however, symptom relief is not achieved even after surgery, or the disease recurs and patients must return for revision surgery .many patients whose symptoms of chronic or recurrent sinusitis persist despite primary FESS and long-term maximal medical therapy, underwent revision FESS
Methods: Prospective, randomized, controlled, clinical trial using an intra patient control design
The study enrolled patients with recurrent or persistent polyposis after primary FESS to compare the effect of autologous Platelet-rich plasma (PRP) using an intra patient control design. After local application of PRP, efficacy of this type of treatment was assessed with Endoscopy and Snot-22 questioner
PRP was selected because of it’s anti-inflammatory effect. PRP will be put locally in involved sinuses with endoscope guidance and the patient will be re-examined and re-evaluated with standard questionnaire and endoscopy 4 weeks later and 9 months later to assess the effect of this novel treatment option.
Results: A total of 16 patients were included in the study. PRP was successfully deployed in all 16 patients. PRP provided symptom relief after the first and ninth month of treatment due to snot-22 questioner. In seven patients (43.75 percent) the endoscopic grade decreased from +2 to +1 after the first month of treatment
Conclusion: This study showed that use of PRP improves patient symptoms according to Snot-22 questioner and endoscopic grading score. There was no correlation between CT-score and response to treatment.
Methods: Prospective, randomized, controlled, clinical trial using an intra patient control design
The study enrolled patients with recurrent or persistent polyposis after primary FESS to compare the effect of autologous Platelet-rich plasma (PRP) using an intra patient control design. After local application of PRP, efficacy of this type of treatment was assessed with Endoscopy and Snot-22 questioner
PRP was selected because of it’s anti-inflammatory effect. PRP will be put locally in involved sinuses with endoscope guidance and the patient will be re-examined and re-evaluated with standard questionnaire and endoscopy 4 weeks later and 9 months later to assess the effect of this novel treatment option.
Results: A total of 16 patients were included in the study. PRP was successfully deployed in all 16 patients. PRP provided symptom relief after the first and ninth month of treatment due to snot-22 questioner. In seven patients (43.75 percent) the endoscopic grade decreased from +2 to +1 after the first month of treatment
Conclusion: This study showed that use of PRP improves patient symptoms according to Snot-22 questioner and endoscopic grading score. There was no correlation between CT-score and response to treatment.
Type of Study: Research |
Subject:
ENT Surgery
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
